CD151

CD151 is a protein that in humans is encoded by the CD151 gene. It is a member of the tetraspanin family, which are cell surface proteins involved in the regulation of cell development, activation, growth, and motility. CD151 is also known as the cluster of differentiation 151.
Structure[edit]
CD151 is a transmembrane protein that spans the cell membrane four times, characteristic of the tetraspanin family. It has two extracellular loops, a small intracellular loop, and short cytoplasmic tails. The large extracellular loop is involved in protein-protein interactions, which are crucial for its function in cell adhesion and signaling.
Function[edit]
CD151 plays a significant role in cell adhesion, migration, and signaling. It is known to associate with integrins, particularly integrin alpha3 and integrin alpha6, forming complexes that are important for the stabilization of cell-cell and cell-matrix interactions. These interactions are critical in processes such as angiogenesis, tumor metastasis, and wound healing.
Clinical Significance[edit]
CD151 has been implicated in various pathological conditions, including cancer. It is often overexpressed in carcinomas and is associated with poor prognosis in several types of cancer, such as breast cancer, prostate cancer, and melanoma. CD151 promotes cancer cell migration and invasion, contributing to metastasis.
In addition to its role in cancer, CD151 is involved in kidney disease. Mutations in the CD151 gene can lead to nephropathy and hearing loss, as seen in some genetic syndromes.
Research[edit]
Research on CD151 is ongoing to better understand its role in disease and its potential as a therapeutic target. Inhibiting CD151 function has been proposed as a strategy to prevent cancer metastasis. Studies are also exploring its role in angiogenesis and its potential impact on cardiovascular disease.
Related pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian